Skin Cancer Treatment - Zelboraf

HONOLULU (HawaiiNewsNow)-Skin cancer is always a big deal in the sun in Hawaii. Anna C. Pavlick is an attending physician at the NYU Medical Center, New York, NY, as well as an associate professor of medicine in the Division of Medical Oncology at NYU School of Medicine.

Dr. Pavlick is Director, NYU Cancer Institute, Division of Medical Oncology, Melanoma Program; Assistant Director, NYU Cancer Institute, Clinical Research and Education and a co-director of the NYU Cancer Center Clinical Research Committee, with responsibilities in the melanoma and translational research committee.

Dr. Pavlick earned her degree in medicine from the University of Medicine & Dentistry of New Jersey; her master of science in human anatomy from Fairleigh Dickinson University in Teaneck, New Jersey; and her bachelor of science and nursing degrees from Fairfield University in Fairfield, Connecticut. She completed her hematology/oncology training at Memorial Sloan Kettering Cancer Center in New York City.

Dr. Pavlick is the author or coauthor of nearly 100 publications and congress presentations, and serves on the several editorial boards.

Richard, an avid gardener from Waterbury, Conn., was diagnosed with metastatic melanoma in 2009 after going to the doctor for a persistent cough caused by a tumor in his lung.  After his initial treatment failed, Richard was referred to Dr. Anna Pavlick at the NYU Medical Center, who tested Richard's tumor for the BRAF mutation.  After testing positive, she enrolled Richard in a clinical trial with Zelboraf .  Since entering the clinical trial, Richard's tumor shrunk by 95% and he was able to see the birth of his first granddaughter in May.

More information on Zelboraf can be seen here.

Copyright HawaiiNewsNow 2011 All Rights Reserved